Literature DB >> 28339984

The link between phenotype and fatty acid metabolism in advanced chronic kidney disease.

Dan-Qian Chen1, Hua Chen1, Lin Chen1, Nosratola D Vaziri2, Ming Wang1, Xiang-Ri Li3, Ying-Yong Zhao1.   

Abstract

BACKGROUND: The kidney plays a central role in elimination of metabolic waste products and regulation of low-molecular weight metabolites via glomerular filtration, tubular secretion and reabsorption. Disruption of these processes results in profound changes in the biochemical milieu of the body fluids, which contribute to complications of chronic kidney disease (CKD) by inducing cytotoxicity and inflammation. Insight into the changes of the composition of metabolites and dysregulation of target genes and proteins enhances the understanding of the pathophysiology of CKD and its complications, and the development of novel therapeutic strategies. Chronic interstitial nephropathy is a common cause of CKD. The present study was designed to determine the effect of chronic interstitial nephropathy on the composition of serum metabolites and regulation of oxidative, inflammatory, fibrotic and cytoprotective pathways.
METHODS: Male Sprague-Dawley rats were randomized to the CKD and control groups ( n  = 8/group). CKD was induced by administration of adenine (200 mg/kg body weight/day) by oral gavage for 3 weeks. The control group was treated with the vehicle alone. The animals were then observed for an additional 3 weeks, at which point they were sacrificed and kidney and serum samples were collected. Serum metabolomic and lipidomic analyses were performed using ultra-performance liquid chromatography-quadrupole time-of-flight high-definition mass spectrometry. Kidney tissues were processed for histological and molecular biochemical analyses.
RESULTS: CKD rats exhibited increased plasma urea and creatinine concentrations, renal interstitial fibrosis, tubular damage and up-regulation of pro-inflammatory, pro-oxidant and pro-fibrotic pathways. Comparison of serum from CKD and control rats revealed significant differences in concentrations of amino acids and lipids including 33 metabolites and 35 lipid species. This was associated with marked abnormalities of fatty acid oxidation, and γ-linolenic acid and linoleic acid metabolism in CKD rats. Logistic regression analysis identified tetracosanoic acid, docosatrienoic acid, PC(18:3/14:1) and l -aspartic acid, tetracosanoic acid and docosatrienoic acid as novel biomarkers of chronic interstitial nephropathy.
CONCLUSIONS: Advanced CKD in rats with adenine-induced chronic interstitial nephropathy results in profound changes in the serum metabolome, activation of inflammatory, oxidative and fibrotic pathways, and suppression of cytoprotective and antioxidant pathways.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  chronic kidney disease; fatty acid oxidation; lipidomics; metabolomics; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28339984     DOI: 10.1093/ndt/gfw415

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  36 in total

1.  DESI-MSI and METASPACE indicates lipid abnormalities and altered mitochondrial membrane components in diabetic renal proximal tubules.

Authors:  Guanshi Zhang; Jialing Zhang; Rachel J DeHoog; Subramaniam Pennathur; Christopher R Anderton; Manjeri A Venkatachalam; Theodore Alexandrov; Livia S Eberlin; Kumar Sharma
Journal:  Metabolomics       Date:  2020-01-10       Impact factor: 4.290

2.  Microbiome-metabolomics reveals gut microbiota associated with glycine-conjugated metabolites and polyamine metabolism in chronic kidney disease.

Authors:  Ya-Long Feng; Gang Cao; Dan-Qian Chen; Nosratola D Vaziri; Lin Chen; Jun Zhang; Ming Wang; Yan Guo; Ying-Yong Zhao
Journal:  Cell Mol Life Sci       Date:  2019-05-30       Impact factor: 9.261

3.  iTRAQ quantitative proteomic analysis differentially expressed proteins and signal pathways in henoch-schönlein purpura nephritis.

Authors:  Ran Gao; Xueli Niu; Lili Zhu; Ruiqun Qi; Liang He
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

4.  Machine learning distilled metabolite biomarkers for early stage renal injury.

Authors:  Yan Guo; Hui Yu; Danqian Chen; Ying-Yong Zhao
Journal:  Metabolomics       Date:  2019-12-05       Impact factor: 4.290

5.  Novel inhibitors of the cellular renin-angiotensin system components, poricoic acids, target Smad3 phosphorylation and Wnt/β-catenin pathway against renal fibrosis.

Authors:  Ming Wang; Dan-Qian Chen; Lin Chen; Gang Cao; Hui Zhao; Dan Liu; Nosratola D Vaziri; Yan Guo; Ying-Yong Zhao
Journal:  Br J Pharmacol       Date:  2018-05-22       Impact factor: 8.739

6.  Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction.

Authors:  Junju Zou; Xiaotao Zhou; Xian Chen; Yuerong Ma; Rong Yu
Journal:  Front Pharmacol       Date:  2022-06-02       Impact factor: 5.988

Review 7.  Novel treatment strategies for chronic kidney disease: insights from the animal kingdom.

Authors:  Peter Stenvinkel; Johanna Painer; Makoto Kuro-O; Miguel Lanaspa; Walter Arnold; Thomas Ruf; Paul G Shiels; Richard J Johnson
Journal:  Nat Rev Nephrol       Date:  2018-01-15       Impact factor: 28.314

Review 8.  Druggability of lipid metabolism modulation against renal fibrosis.

Authors:  Yuan-Yuan Chen; Xiao-Guang Chen; Sen Zhang
Journal:  Acta Pharmacol Sin       Date:  2021-05-14       Impact factor: 6.150

9.  Multi-Solvent Extraction Procedure for the Pioneer Fecal Metabolomic Analysis-Identification of Potential Biomarkers in Stable Kidney Transplant Patients.

Authors:  Soumaya Kouidhi; Nessrine Souai; Muhanad Alhujaily; Oumaima Zidi; Ameni Kochbati; Alaeddine Redissi; Tareg M Belali; Imene El Kossai; Jamelddine El Manaa; Ameur Cherif; Wissem Mnif; Amor Mosbah
Journal:  Diagnostics (Basel)       Date:  2021-05-26

10.  Axl-inhibitor bemcentinib alleviates mitochondrial dysfunction in the unilateral ureter obstruction murine model.

Authors:  August Hoel; Tarig Osman; Fredrik Hoel; Hassan Elsaid; Tony Chen; Lea Landolt; Janka Babickova; Karl Johan Tronstad; James B Lorens; Gro Gausdal; Hans-Peter Marti; Jessica Furriol
Journal:  J Cell Mol Med       Date:  2021-07-05       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.